330.1: Higher Immunogenicity of a Third Heterologous Dose With BNT262b2 mRNA Vaccine Compared to a Homologous Dose in Kidney Transplant Recipients Fully Vaccinated With Inactivated Whole-Virion Coronavac Vaccine. (13th September 2022)